Dystrogen Therapeutics Corp — Form D

Dystrogen Therapeutics Corp of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-07. The offering totals $5.0M, of which $1.1M was reported sold. Industry: Other Health Care.

Offering

• Filed: 2019-08-07
• Form: D
• Accession: 0001778074-19-000002
• Industry: Other Health Care
• Exemptions: 06b
• Total offering: $5.0M
• Amount sold: $1.1M
• Remaining: $3.9M
• Minimum investment: $85
• Investors: 14
• Date of first sale: 2019-08-05
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-346014

Issuer

• Name: Dystrogen Therapeutics Corp
• CIK: 0001778074
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2017
• Address: 1415 W. 37TH STREET, CHICAGO, IL, 60609
• Phone: 2164101829

Officers, directors & promoters (1)

More

• CIK 1778074 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search